Do analysts recommend ULBI or ABAT?

American Battery Technology has a consensus target price of $6.00, indicating a potential upside of 174.60%. Given American Battery Technology's stronger consensus rating and higher possible upside, analysts clearly believe American Battery Technology is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 American Battery Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Do analysts recommend ELVA or ULBI?

Electrovaya presently has a consensus target price of $17.50, suggesting a potential upside of 167.18%. Given Electrovaya's stronger consensus rating and higher probable upside, equities analysts clearly believe Electrovaya is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electrovaya 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ULBI or MVST?

Microvast has a consensus target price of $4.00, indicating a potential upside of 529.92%. Given Microvast's stronger consensus rating and higher possible upside, analysts plainly believe Microvast is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Microvast 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is ULBI or MVST more profitable?

Microvast has a net margin of 13.95% compared to Ultralife's net margin of -3.50%. Ultralife's return on equity of 2.75% beat Microvast's return on equity. Company Net Margins Return on Equity Return on Assets Ultralife -3.50% 2.75% 1.66% Microvast 13.95% -10.34% -4.64%

Do analysts prefer CHPT or ULBI?

ChargePoint currently has a consensus target price of $6.93, suggesting a potential downside of 24.57%. Given ChargePoint's stronger consensus rating and higher possible upside, research analysts clearly believe ChargePoint is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ChargePoint 3 Sell rating(s) 8 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.73 Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CHPT or ULBI more profitable?

Ultralife has a net margin of -3.50% compared to ChargePoint's net margin of -40.59%. Ultralife's return on equity of 2.75% beat ChargePoint's return on equity. Company Net Margins Return on Equity Return on Assets ChargePoint -40.59% -3,366.29% -15.95% Ultralife -3.50% 2.75% 1.66%

Do analysts rate ULBI or NEOV?

NeoVolta has a consensus price target of $9.50, indicating a potential upside of 167.61%. Given NeoVolta's stronger consensus rating and higher possible upside, analysts clearly believe NeoVolta is more favorable than Ultralife. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ultralife 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NeoVolta 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43

Is ULBI or NEOV more profitable?

Ultralife has a net margin of -3.50% compared to NeoVolta's net margin of -63.35%. Ultralife's return on equity of 2.75% beat NeoVolta's return on equity. Company Net Margins Return on Equity Return on Assets Ultralife -3.50% 2.75% 1.66% NeoVolta -63.35% -141.89% -89.61%

Ultralife (ULBI) Competitors

$5.54 +0.09 (+1.72%)

As of 10:19 AM Eastern

Compare

ULBI vs. ABAT, ELVA, MVST, CHPT, and NEOV

Should you buy Ultralife stock or one of its competitors? Ultralife's main competitors and comparable companies include American Battery Technology (ABAT), Electrovaya (ELVA), Microvast (MVST), ChargePoint (CHPT), and NeoVolta (NEOV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "electrical components & equipment" industry.

How does Ultralife compare to American Battery Technology?

Ultralife (NASDAQ:ULBI) and American Battery Technology (NASDAQ:ABAT) are both small-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Ultralife has higher revenue and earnings than American Battery Technology. Ultralife is trading at a lower price-to-earnings ratio than American Battery Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ultralife	$191.16M	0.48	-$5.90M	-$0.40	N/A
American Battery Technology	$21.74M	14.33	-$46.76M	-$0.52	N/A

Ultralife has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market. Comparatively, American Battery Technology has a beta of 0.32, meaning that its stock price is 68% less volatile than the broader market.

American Battery Technology has a consensus target price of $6.00, indicating a potential upside of 174.60%. Given American Battery Technology's stronger consensus rating and higher possible upside, analysts clearly believe American Battery Technology is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
American Battery Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Ultralife has a net margin of -3.50% compared to American Battery Technology's net margin of -337.50%. Ultralife's return on equity of 2.75% beat American Battery Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ultralife	-3.50%	2.75%	1.66%
American Battery Technology	-337.50%	-64.63%	-61.52%

30.7% of Ultralife shares are held by institutional investors. Comparatively, 9.9% of American Battery Technology shares are held by institutional investors. 42.9% of Ultralife shares are held by company insiders. Comparatively, 2.8% of American Battery Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, American Battery Technology had 7 more articles in the media than Ultralife. MarketBeat recorded 8 mentions for American Battery Technology and 1 mentions for Ultralife. Ultralife's average media sentiment score of 1.89 beat American Battery Technology's score of 0.28 indicating that Ultralife is being referred to more favorably in the media.

Company	Overall Sentiment
Ultralife	Very Positive
American Battery Technology	Neutral

Summary

Ultralife beats American Battery Technology on 10 of the 16 factors compared between the two stocks.

How does Ultralife compare to Electrovaya?

Electrovaya (NASDAQ:ELVA) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Electrovaya has higher earnings, but lower revenue than Ultralife. Ultralife is trading at a lower price-to-earnings ratio than Electrovaya, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electrovaya	$63.83M	5.08	$3.36M	$0.11	59.55
Ultralife	$191.16M	0.48	-$5.90M	-$0.40	N/A

Electrovaya has a net margin of 6.14% compared to Ultralife's net margin of -3.50%. Electrovaya's return on equity of 7.96% beat Ultralife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electrovaya	6.14%	7.96%	4.54%
Ultralife	-3.50%	2.75%	1.66%

Electrovaya has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

Electrovaya presently has a consensus target price of $17.50, suggesting a potential upside of 167.18%. Given Electrovaya's stronger consensus rating and higher probable upside, equities analysts clearly believe Electrovaya is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electrovaya	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.83
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

22.5% of Electrovaya shares are held by institutional investors. Comparatively, 30.7% of Ultralife shares are held by institutional investors. 42.9% of Ultralife shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Electrovaya and Electrovaya both had 1 articles in the media. Ultralife's average media sentiment score of 1.89 beat Electrovaya's score of 1.18 indicating that Ultralife is being referred to more favorably in the news media.

Company	Overall Sentiment
Electrovaya	Positive
Ultralife	Very Positive

Summary

Electrovaya beats Ultralife on 12 of the 16 factors compared between the two stocks.

How does Ultralife compare to Microvast?

Ultralife (NASDAQ:ULBI) and Microvast (NASDAQ:MVST) are both small-cap industrials companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.

Ultralife has higher earnings, but lower revenue than Microvast. Microvast is trading at a lower price-to-earnings ratio than Ultralife, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ultralife	$191.16M	0.48	-$5.90M	-$0.40	N/A
Microvast	$427.52M	0.57	-$29.22M	-$0.02	N/A

In the previous week, Microvast had 23 more articles in the media than Ultralife. MarketBeat recorded 24 mentions for Microvast and 1 mentions for Ultralife. Ultralife's average media sentiment score of 1.89 beat Microvast's score of 0.11 indicating that Ultralife is being referred to more favorably in the media.

Company	Overall Sentiment
Ultralife	Very Positive
Microvast	Neutral

30.7% of Ultralife shares are owned by institutional investors. Comparatively, 20.7% of Microvast shares are owned by institutional investors. 42.9% of Ultralife shares are owned by company insiders. Comparatively, 44.8% of Microvast shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Ultralife has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Microvast has a beta of 3.55, meaning that its share price is 255% more volatile than the broader market.

Microvast has a consensus target price of $4.00, indicating a potential upside of 529.92%. Given Microvast's stronger consensus rating and higher possible upside, analysts plainly believe Microvast is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Microvast	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Microvast has a net margin of 13.95% compared to Ultralife's net margin of -3.50%. Ultralife's return on equity of 2.75% beat Microvast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ultralife	-3.50%	2.75%	1.66%
Microvast	13.95%	-10.34%	-4.64%

Summary

Microvast beats Ultralife on 10 of the 16 factors compared between the two stocks.

How does Ultralife compare to ChargePoint?

ChargePoint (NYSE:CHPT) and Ultralife (NASDAQ:ULBI) are both small-cap industrials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Ultralife has lower revenue, but higher earnings than ChargePoint. Ultralife is trading at a lower price-to-earnings ratio than ChargePoint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ChargePoint	$411.22M	0.60	-$220.20M	-$7.18	N/A
Ultralife	$191.16M	0.48	-$5.90M	-$0.40	N/A

ChargePoint currently has a consensus target price of $6.93, suggesting a potential downside of 24.57%. Given ChargePoint's stronger consensus rating and higher possible upside, research analysts clearly believe ChargePoint is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ChargePoint	3 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.73
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ultralife has a net margin of -3.50% compared to ChargePoint's net margin of -40.59%. Ultralife's return on equity of 2.75% beat ChargePoint's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ChargePoint	-40.59%	-3,366.29%	-15.95%
Ultralife	-3.50%	2.75%	1.66%

ChargePoint has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, Ultralife has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

37.8% of ChargePoint shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 4.2% of ChargePoint shares are owned by insiders. Comparatively, 42.9% of Ultralife shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, ChargePoint had 2 more articles in the media than Ultralife. MarketBeat recorded 3 mentions for ChargePoint and 1 mentions for Ultralife. Ultralife's average media sentiment score of 1.89 beat ChargePoint's score of 0.68 indicating that Ultralife is being referred to more favorably in the news media.

Company	Overall Sentiment
ChargePoint	Positive
Ultralife	Very Positive

Summary

ChargePoint beats Ultralife on 8 of the 15 factors compared between the two stocks.

How does Ultralife compare to NeoVolta?

Ultralife (NASDAQ:ULBI) and NeoVolta (NASDAQ:NEOV) are both small-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

In the previous week, NeoVolta had 8 more articles in the media than Ultralife. MarketBeat recorded 9 mentions for NeoVolta and 1 mentions for Ultralife. Ultralife's average media sentiment score of 1.89 beat NeoVolta's score of 0.78 indicating that Ultralife is being referred to more favorably in the media.

Company	Overall Sentiment
Ultralife	Very Positive
NeoVolta	Positive

Ultralife has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market. Comparatively, NeoVolta has a beta of -0.87, suggesting that its share price is 187% less volatile than the broader market.

NeoVolta has lower revenue, but higher earnings than Ultralife. Ultralife is trading at a lower price-to-earnings ratio than NeoVolta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ultralife	$191.16M	0.48	-$5.90M	-$0.40	N/A
NeoVolta	$8.43M	23.84	-$5.03M	-$0.33	N/A

NeoVolta has a consensus price target of $9.50, indicating a potential upside of 167.61%. Given NeoVolta's stronger consensus rating and higher possible upside, analysts clearly believe NeoVolta is more favorable than Ultralife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ultralife	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NeoVolta	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Ultralife has a net margin of -3.50% compared to NeoVolta's net margin of -63.35%. Ultralife's return on equity of 2.75% beat NeoVolta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ultralife	-3.50%	2.75%	1.66%
NeoVolta	-63.35%	-141.89%	-89.61%

30.7% of Ultralife shares are owned by institutional investors. Comparatively, 5.1% of NeoVolta shares are owned by institutional investors. 42.9% of Ultralife shares are owned by company insiders. Comparatively, 4.0% of NeoVolta shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Ultralife and NeoVolta tied by winning 8 of the 16 factors compared between the two stocks.

Get Ultralife News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ULBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ULBI vs. The Competition

Export

Metric	Ultralife	Electrical Equipment Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$91.13M	$9.99B	$10.18B	$14.93B
Dividend Yield	N/A	2.35%	97.16%	12.31%
P/E Ratio	-13.88	44.33	25.45	25.33
Price / Sales	0.48	1,619.18	288.30	87.33
Price / Cash	9.04	31.35	23.67	50.90
Price / Book	0.71	7.00	4.76	6.24
Net Income	-$5.90M	$139.36M	$613.19M	$358.55M
7 Day Performance	-1.77%	-3.55%	-0.84%	-1.20%
1 Month Performance	-23.66%	-8.88%	-5.21%	-4.26%
1 Year Performance	-18.86%	2.61%	4.42%	5.47%

Ultralife Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ULBI Ultralife	0.9072 of 5 stars	$5.54 +1.7%	N/A	-19.5%	$91.63M	$191.16M	N/A	678	Positive News
ABAT American Battery Technology	1.7925 of 5 stars	$2.81 +1.1%	$6.00 +113.5%	-14.9%	$379.23M	$16.28M	N/A	54	Earnings Report
ELVA Electrovaya	3.2322 of 5 stars	$7.15 +3.6%	$17.50 +144.8%	+3.9%	$341.60M	$63.83M	65.01	97	Positive News
MVST Microvast	3.1042 of 5 stars	$0.68 -1.3%	$4.00 +486.3%	-81.9%	$265.83M	$427.52M	N/A	1,908
CHPT ChargePoint	1.3479 of 5 stars	$9.41 -4.9%	$6.93 -26.4%	-16.5%	$241.47M	$432.89M	N/A	1,440	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ULBI) was last updated on 9/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ultralife (ULBI) Competitors

ULBI vs. ABAT, ELVA, MVST, CHPT, and NEOV

How does Ultralife compare to American Battery Technology?

Summary

How does Ultralife compare to Electrovaya?

Summary

How does Ultralife compare to Microvast?

Summary

How does Ultralife compare to ChargePoint?

Summary

How does Ultralife compare to NeoVolta?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULBI vs. The Competition

Ultralife Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ultralife (ULBI) Competitors

ULBI vs. ABAT, ELVA, MVST, CHPT, and NEOV

How does Ultralife compare to American Battery Technology?

Which has higher valuation & earnings, ULBI or ABAT?

Which has more volatility and risk, ULBI or ABAT?

Do analysts recommend ULBI or ABAT?

Is ULBI or ABAT more profitable?

Do institutionals & insiders hold more shares of ULBI or ABAT?

Does the media prefer ULBI or ABAT?

Summary

How does Ultralife compare to Electrovaya?

Which has preferable valuation & earnings, ELVA or ULBI?

Is ELVA or ULBI more profitable?

Which has more volatility & risk, ELVA or ULBI?

Do analysts recommend ELVA or ULBI?

Do insiders & institutionals have more ownership in ELVA or ULBI?

Does the media refer more to ELVA or ULBI?

Summary

How does Ultralife compare to Microvast?

Which has higher valuation and earnings, ULBI or MVST?

Does the media prefer ULBI or MVST?

Do institutionals & insiders believe in ULBI or MVST?

Which has more volatility and risk, ULBI or MVST?

Do analysts prefer ULBI or MVST?

Is ULBI or MVST more profitable?

Summary

How does Ultralife compare to ChargePoint?

Which has stronger earnings & valuation, CHPT or ULBI?

Do analysts prefer CHPT or ULBI?

Is CHPT or ULBI more profitable?

Which has more volatility and risk, CHPT or ULBI?

Do institutionals & insiders hold more shares of CHPT or ULBI?

Does the media refer more to CHPT or ULBI?

Summary

How does Ultralife compare to NeoVolta?

Does the media prefer ULBI or NEOV?

Which has more volatility and risk, ULBI or NEOV?

Which has higher valuation & earnings, ULBI or NEOV?

Do analysts rate ULBI or NEOV?

Is ULBI or NEOV more profitable?

Do institutionals & insiders have more ownership in ULBI or NEOV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ULBI vs. The Competition

Ultralife Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools